The Book of PeptidesThe Book of PeptidesLys-Glu (KE)
The Book of Peptides is not a clinic and not your doctor. We do not sell, prescribe, recommend, or personalize any compound, and no grade or ranking here is an endorsement. None of the compounds covered are approved for the uses described here by the U.S. FDA, Australia's Therapeutic Goods Administration (TGA), New Zealand's Medsafe, or the equivalent regulator in most other countries.
Most are sold for laboratory research only, a few are prescription-only drugs, and some are controlled substances or banned in sport. Possessing or administering an unapproved compound outside an authorized setting may be unlawful wherever you live. Nothing here is a recommendation to buy, possess, or self-administer anything. Consult a licensed physician before any decision involving peptide use.
Cross-checked against 50–100 independent sources per claim — the house standard. How this reference is checked
Reference values as published in the research record — not a recommendation, instruction, or dose suggestion for any person. Not medical advice.
Not reconstituted — vials delivery, so there's no vial to draw from.
Vilon is the synthesized dipeptide Lys-Glu from the Khavinson bioregulator program — not extracted from calf thymus as marketing copy claims, so Thymalin's human record does not transfer. Its own human data: two Advances in Gerontology reports (Kuznik, 2006 and 2007) using 10 mcg intramuscularly, once daily for 10 days in type 1 diabetes. No Western trial, approval, registration we could locate, independent replication, or regulator-issued contraindication list — absence of scrutiny, not clearance.
The member edition is the full write-up: every claim cross-checked against independent sources and challenged before print. What didn't survive the check isn't in here.
The full published spec sheet — dose units, timing, frequency, and cycle length — is included with membership.
The published dose for this compound, shown as reference. Included with membership.